About Biomodex
Biomodex is a company based in Paris (France) founded in 2014 was acquired by Mentice in January 2023. Biomodex has raised $18.6 million across 2 funding rounds from investors including Idinvest Partners, Mentice and Innovation Capital. Biomodex offers products and services including Biorealistic Haptic Simulators and 3D Printed Models. Biomodex operates in a competitive market with competitors including eCential Robotics, SentiAR, Axial3D, Enhatch and inHEART, among others.
- Headquarter Paris, France
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomodex Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.6 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series A
May 31, 2018
-
Investors
Idinvest Partners
& 5 more
-
Employee Count
Not available
-
Acquired by
Mentice
(Jan 22, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomodex
Biomodex offers a comprehensive portfolio of products and services, including Biorealistic Haptic Simulators and 3D Printed Models.
Enables realistic medical training with 3D models for procedure rehearsals
Facilitates patient-specific practice for advanced physician education quickly
Funding Insights of Biomodex
Biomodex has successfully raised a total of $18.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomodex
Biomodex has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Idinvest Partners, Mentice and Innovation Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are provided to low and middle market companies.
|
Locked | Locked | Locked | |
|
Private equity investments are made in France and the US.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Biomodex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomodex
Investment portfolio details for Biomodex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomodex
Detailed financials for Biomodex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomodex Comparisons
Peer comparison for Biomodex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomodex
Biomodex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eCential Robotics, SentiAR, Axial3D, Enhatch and inHEART, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
A 3D visualization platform is offered for interventional cardiac procedures.
|
|
| Locked | Locked | Locked |
Provider of cloud-based 3D-printed medical models and surgical guides
|
|
| Locked | Locked | Locked |
Provider of mobile enterprise apps for Salesforce
|
|
| Locked | Locked | Locked |
AI-based 3D cardiac models are developed for therapeutic planning.
|
Detailed competitors of Biomodex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomodex
Complete news archive for Biomodex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomodex
Biomodex was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Biomodex is headquartered in Paris, France.
Biomodex is a funded company, having raised a total of $18.6M across 2 funding rounds to date.
Biomodex develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. The company uses techniques three-dimensional modeling and advanced 3D printers to produce exact copies of organs that can be used to train staff medical and under preoperative simulations. From biomedical imaging data of organs from MRI or scanners, the company has developed a process that helps to automate the creation of virtual 3D models of these organs which can then be printed using a 3D printer. Products are offered for bone drilling, soft tissue suturing, and medical device implantation and sizing, including pathology specifications, medical imaging segmentation, biomechanical modeling, organ 3D printing, simulation environment, and surgical simulation procedures. The company received an investment of 3.6M led by Innovation Capital to expand in the US.
Biomodex's top competitors include eCential Robotics, Axial3D and LensAR.
Biomodex offers Biorealistic Haptic Simulators and 3D Printed Models.
Biomodex has 6 investors. Key investors include Idinvest Partners, Mentice, Innovation Capital, Allianz, and LBO France.